- Stocks Telegraph
- Posts
- 23 Nov - Morning Newsletter (with changes)
23 Nov - Morning Newsletter (with changes)
4 Skyrocketing Stocks to Watch
Good Morning!
The stock markets have started the new trading week very weakly. At the opening of the American stock exchanges, new records appeared on the price boards. Investors initially reacted enthusiastically to the reappointment of Fed Chairman Jerome Powell by Joe Biden. Not much later, interest rates started to rise sharply, causing shares to suddenly turn 180 degrees. The American 10-year yield climbed by more than 9 basis points to more than 1.63%.This caused a huge shock reaction, especially with the Nasdaq. The index opened one percent higher, but ended up closing 1.26% lower. The S&P 500 showed a similar picture, but was able to limit the loss to 0.32%. However, an ugly candle has been left behind on both charts. This bearish engulfing candle is marking the top for now and investors may need to anticipate more selling pressure. The S&P 500 future is already 0.29% lower and the Nasdaq is down another 0.41%.
3 Hot Biotech Breakthroughs to Bank On Now... and Why
Biotech breakthroughs by nature are part of incredibly innovative companies that are disruptors that are redefining the world we live in. And right now, the stocks working hardest toward transformational therapies... and that means some of the biggest opportunities for investors right now. In my latest research report, I share my insights on the biotech sector and give you the names of my top 3 picks.
Today Top Movers
iSpecimen Inc. (ISPC) stock soared 102.7% to $18.0 in the pre-market trading after reporting that it has been contracted to support new advanced research on COVID-19 seeking insights on its transmissibility, variants, outcomes, and testing validity among multiple population segments.
Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) shares are trading up 21.16% at $0.564 at the time of writing after announcing the publication of “Sangivamycin is highly effective against SARS-CoV-2 in vitro and has favorable drug properties,” in JCI Insight.
Aadi Bioscience Inc. (AADI) grew over 54.78% at $39.5 in pre-market trading today after announced that the U.S. Food and Drug Administration (FDA) has approved FYARRO for intravenous use for the treatment of adult patients with locally advanced unresectable or metastatic malignant perivascular epithelioid cell tumor.
Qualigen Therapeutics Inc. (QLGN), a Biotechnology company, rose about 65.6% at $2.07 in pre-market trading Tuesday following the strong quarterly results.
Investor Alert: "Cooling Gas Shortage" Threatens SpaceX
SpaceX (and many other tech giants) are buying up helium like crazy. And that's because the world is running out of this incredibly valuable gas! In fact, prices have already skyrocketed by 160% in the past few years...
Top Upgrades & Downgrades
Mizuho turned bullish on Western Digital Corporation (WDC), upgrading the stock to "Buy" and assigning a $75.00 price target, representing potential upside of 31.74% from Monday's close.
Micron Technology Inc. (MU) has won the favor of Mizuho's equity research team. The firm upgraded the shares from Neutral to Buy and moved their price target to $95.00, suggesting 13.28% additional upside for the stock.
TransUnion (TRU) received an upgrade from analysts at Atlantic Equities, who also set their one-year price target on the stock to $140.00. They changed their rating on TRU to Overweight from Neutral in a recently issued research note.
Earlier Tuesday Baird reduced its rating on Vonage Holdings Corp. (VG) stock to Neutral from Outperform and assigned the price target to $21.00.
Cowen & Co. analysts reduced their investment ratings, saying in research reports covered by the media that its rating for Spruce Biosciences, Inc. (SPRB) has been changed to Market Perform from Outperform.
Analysts at CIBC downgraded Pembina Pipeline Corporation (PBA)'s stock to Neutral from Outperformer Tuesday.
The Truth about Cryptocurrency - PLUS, 3 Crypto Picks on the Move
The crypto market matured in 2021, and investor demand is soaring! Large companies like Tesla, Goldman Sachs, Fidelity and major institutional investors are also piling in. This trend has created a safer way for investors to play the crypto boom. In my research report, I will share the inside scoop on cryptos and give you my top 3 crypto picks.
Latest Insider Activity
Ford Motor Company (F) Chief People & E. Exp. Officer Robinson Kiersten announced the sale of shares taking place on Nov 22 at $20.43 for some 17,713 shares. The total came to more than $0.36 million.
NVIDIA Corporation (NVDA) Director Drell Persis sold on Nov 19 a total 41,200 shares at $326.65 on average. The insider’s sale generated proceeds of almost $3.27 million.
Canoo Inc. (GOEV) Executive Chairman and CEO Aquila Tony declared the purchase of shares taking place on Nov 22 at $6.53 for some 35,273,268 shares. The transaction amount was around $230.33 million.
Zomedica Corp. (ZOM) Director POWERS JOHNNY D bought on Nov 18 a total 1,500,000 shares at $0.45 on average. The purchase cost the insider an estimated $112,500.
The Top 5 Stocks to Own Now for 2022
When it comes to investing, one of your top goals has been to achieve financial freedom.
So, it stands to reason your money should ideally be able to generate above-market returns with below market risk. After all, that's how real wealth is created. To help, we put together a list of five of the top stocks we believe could do quite well heading into New Year 2022.
Important Earnings
Top US earnings releases scheduled for today include HP Inc. (NYSE:HPQ). It will announce its Oct 2021 financial results. The company is expected to report earnings of $0.88 per share from revenues of $15.4B in the three-month period.
Analysts expect The Gap Inc. (NYSE:GPS) to report a net income (adjusted) of $0.5 per share, when the company releases its quarterly results shortly. Revenue for the fiscal quarter ended Oct 2021 is predicted to come in at $4.44B.
Dell Technologies Inc. (DELL), due to announce earnings after the market closes today, is expected to report earnings of $2.18 per share from revenues of $26.82B recently concluded three-month period.
That's it for today. Thanks for reading. Good luck out there!Best Regards,Stocks Telegraph Team
P.S. Want my daily watchlists sent to your cell phone too? Just go HERE and join my text message list!
Disclaimer: Legal Stuff: Stocks featured in this newsletter are for entertainment purposes only. You should not base any investment decisions on information contained in my newsletter. Stocks featured in this newsletter may be owned by owners/operators of this website which could impact our ability to remain unbiased. Please consult a financial advisor before making any trading decisions. I may earn a small commission from links placed inside of these emails.